Myocardial infarction, ischaemic stroke and pulmonary embolism before and after breast cancer hospitalization: A population-based study

Thrombosis and Haemostasis

Volumn 106, Issue 1, 2011, Pages 1-7

  van Herk Sukel, Myrthe P P ^a   Shantakumar, Sumitra ^b   Kamphuisen, Pieter W ^c   Penning van Beest, Fernie J A ^a   Herings, Ron M C ^a,d  

^a Institute for Drug Outcome Research   (Netherlands)

^b GLAXOSMITHKLINE   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Incidence; Ischaemic stroke; Myocardial infarction; Pulmonary embolism; Risk factors

Indexed keywords

ADULT; ARTICLE; BRAIN ISCHEMIA; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; DRUG USE; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; AGED; BREAST TUMOR; CARCINOMA; ETHNIC AND RACIAL GROUPS; INCIDENCE; ISCHEMIA; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICS; STROKE; TIME; CHEMOTHERAPY; FOLLOW UP; HORMONAL THERAPY; OUTCOME ASSESSMENT; SENSITIVITY ANALYSIS; THROMBOEMBOLISM;

AGED; BREAST NEOPLASMS; CARCINOMA; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; ISCHEMIA; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; POPULATION GROUPS; PREVALENCE; PULMONARY EMBOLISM; RISK FACTORS; STROKE; TIME FACTORS;

EID: 82255169298     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Buller HR, van Doormaal FF, van Sluis GL, et al. Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost 2007; 5 (Suppl 1): 246-254.
2. Khorana AA. Cancer and thrombosis: implications of published guidelines for clinical practice. Ann Oncol 2009; 20: 1619-1630.
3. Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005; 6: 401-410.
4. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160: 809-815.
5. Khorana AA, Connolly GC. Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol 2009; 27: 4839-4847.
6. Khorana AA, Francis CW, Culakova E, et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007; 110: 2339-2346.
7. Stein PD, Beemath A, Meyers FA, et al. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 2006; 119: 60-68.
8. Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006; 166: 458-464.
9. Kuderer NM, Ortel TL, Francis CW. Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol 2009; 27: 4902-4911.
10. Blom JW, Vanderschoot JP, Oostindier MJ, et al. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 2006; 4: 529-535.
11. Chew HK, Wun T, Harvey DJ, et al. Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol 2007; 25: 70-76.
12. White RH, Chew HK, Zhou H, et al. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med 2005; 165: 1782-1787.
13. Di Nisio M, Ferrante N, De Tursi M, et al. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Thromb Haemost 2010; 104: 1049-1054.
14. Paneesha S, McManus A, Arya R, et al. Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics. Thromb Haemost 2010; 103: 338-343.
15. Javid M, Magee TR, Galland RB. Arterial thrombosis associated with malignant disease. Eur J Vasc Endovasc Surg 2008; 35: 84-87.
16. Dutch Hospital Data. Available at: http://www.dutchhospitaldata.nl.
17. So L, Evans D, Quan H. ICD-10 coding algorithms for defining comorbidities of acute myocardial infarction. BMC Health Serv Res 2006; 6: 161.
18. Roumie CL, Mitchel E, Gideon PS, et al. Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiol Drug Saf 2008; 17: 20-26.
19. Wolinsky FD, Wan GJ, Gurney JG, et al. The risk of hospitalization for ischemic stroke among older adults. Med Care 1998; 36: 449-461.
20. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med 2003; 163: 1711-1717.
21. Kniffin WD, Jr., Baron JA, Barrett J, et al. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154: 861-866.
22. Breslow NE, Day NE. Statistical methods in cancer research, Volume II: The design and analysis of cohort studies. Lyon: IARC Scientific Publications No. 82; 1989. pp. 69-72.
23. Otten HM, Prins MH. Venous thromboembolism and occult malignancy. Thromb Res 2001; 102: V187-194.
24. Piccioli A, Prandoni P. Venous thromboembolism as first manifestation of cancer. Acta Haematol 2001; 106: 13-17.
25. Blom JW, Doggen CJ, Osanto S, et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. J Am Med Assoc 2005; 293: 715-722.
26. Trentham-Dietz A, Newcomb PA, Egan KM, et al. Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 2000; 11: 533-542.
27. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322: 882-889.
28. Janssen-Heijnen ML, Szerencsi K, van de Schans SA, et al. Cancer patients with cardiovascular disease have survival rates comparable to cancer patients within the age-cohort of 10 years older without cardiovascular morbidity. Crit Rev Oncol Hematol 2010; 76: 196-207.
29. Sukel MP, Breekveldt-Postma NS, Erkens JA, et al. Incidence of cardiovascular events in breast cancer patients receiving chemotherapy in clinical practice. Pharmacoepidemiol Drug Saf 2008; 17: 125-134.
30. Jones LW, Haykowsky MJ, Swartz JJ, et al. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 2007; 50: 1435-1441.
31. Lenihan DJ, Esteva FJ. Multidisciplinary strategy for managing cardiovascular risks when treating patients with early breast cancer. Oncologist 2008; 13: 1224-1234.
32. McDonald CC, Alexander FE, Whyte BW, et al. Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast Group. Br Med J 1995; 311: 977-980.
33. Saphner T, Tormey DC, Gray R. Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 1991; 9: 286-294.
34. Zidane M, van Hulsteijn LH, Brenninkmeijer BJ, et al. Out of hospital treatment with subcutaneous low molecular weight heparin in patients with acute deepvein thrombosis: a prospective study in daily practice. Haematologica 2006; 91: 1052-1058.
35. van Herk-Sukel MP, van de Poll-Franse LV, Lemmens VE, et al. New opportunities for drug outcomes research in cancer patients: The linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System. Eur J Cancer 2010; 46: 395-404.